$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[국내논문] 알츠하이머병 환자의 이상행동심리증상(BPSD)에 대한 한약과 양약의 병용 효과에 대한 연구: 체계적 문헌 고찰
A Study on the Combination Effect of Herbal Medicine and Western Medicine on BPSD in Patients with Alzheimer's Disease: A Systematic Review 원문보기

동의신경정신과학회지 = Journal of oriental neuropsychiatry, v.31 no.4, 2020년, pp.301 - 314  

김만기 (동국대학교 한의과대학 한방신경정신과학교실) ,  장석주 (동국대학교 한의과대학 한방소아청소년과학교실) ,  홍민호 (동국대학교 한의과대학 한방신경정신과학교실) ,  김근우 (동국대학교 한의과대학 한방신경정신과학교실) ,  구병수 (동국대학교 한의과대학 한방신경정신과학교실)

Abstract ▼ AI-Helper 아이콘AI-Helper

Objectives: The purpose of this study was to provide clinical evidence to support the use of herbal medicine combined with western medicine for BPSD. Methods: Studies were identified by searching CNKI, Pubmed, EMBASE, Cochrane Library, SCIENCEON, RISS, KMbase, KISS, OASIS. Literature searches of Chi...

주제어

#BPSD   #Behavioral and Psychological Symptoms of Dementia   #Herbal medicine   #Combined therapy  

표/그림 (6)

참고문헌 (29)

  1. Chakraborty S, Lennon JC, Malkaram SA, Zeng Y, Fisher DW, Dong H. Serotonergic system, cognition, and BPSD in Alzheimer's disease. Neuroscience Letters. 2019;21: 36-44. 

  2. Han SH. Behavioral and Psychological Symptoms of Dementia: An Overview. Dementia and Neurocognitive Disorders. 2004;3:1-4. 

  3. Kim CH. Behavioral Disturbances in BPSD. Korean Association for Geriatric Psychiatry. 2000;4(1):17-23. 

  4. Korean Neuropsychiatric Association. Textbook of neuropsychiatry. iMiS COMPANY. 2016;581. 

  5. Fiest KM, Roberts JI, Maxwell CJ, Hogan DB, Smith EE, Frolkis A, Cohen A, Kirk A, Pearson D, Pringsheim T, Venegas-Torres A, Jette N. The Prevalence and Incidence of Dementia Due to Alzheimer's Disease: a Systematic Review and Meta- Analysis. Canadian Journal of Neurological Sciences. 2016;43(Suppl 1):S51-82. 

  6. Park UJ. Trends Analysis of Characteristics in Patient with Dementia. Journal of the Korea Academia-Industrial cooperation Society. 2017;18(1):202-9. 

    원문보기 상세보기 crossref

  7. Bessey LJ, Walaszek A. Management of Behavioral and Psychological Symptoms of Dementia. Current Psychiatry Reports. 2019;21(8):66. 

    상세보기 crossref

  8. The Textbook Compilation Committee of Neuropsychiatry of Oriental Schools in Nation. The Neuropsychiatry of Oriental Medicine 3rd Edition. Jipmoondang. 2018;319-27. 

  9. Lee DH, Analysis of Clinical Korean Medicine Studies on Dementia : Focused on Korean Literatures for 10 Years. Journal of Society of Preventive Korean Medicine. 2020; 24(1):37-48. 

  10. Yoon KJ, Lee AY, Kim HS, Choi JH, Lee JA, Kim NK, Hwang DK, Lee SY. Evaluation and study of the 2nd stage pilot project in collaboration with western medicine and oriental medicine. Korea Institute for Health and Social Affairs. 2018;3-10. 

  11. Han M. Clinical Observation on Jianwei Yunao Decoction in Treating for Alzheimer's Disease with Qi and Blood Deficiency Syndrome. Acta chinese medicine. 2018;33: 878-81. 

  12. Lin Y, Chu W, Tang Y. Clinical Observation of Aripiprazole Combined with Fufang Haishe Capsule in Treating Alzheimer's Disease. Journal of New Chinese Medicine. 2016;48(12): 26-7. 

  13. Pan W, Wang Q, Kwak S, Song Y, Qin B, Wang M, Yamamoto Y. Shen-Zhi-Ling Oral Liquid Improves Behavioral and Psychological Symptoms of Dementia in Alzheimer's Disease. Evidence-Based Complementary and Alternative Medicine. 2014:1-6. 

  14. Ringman J, Frautschy S, Teng E, Begum A, Bardens J, Beigi M, Gylys K, Badmaev V, Heath D, Apostolova L, Porter V, Vanek Z, Marshall G, Hellemann G, Sugar C, Masterman D, Montine T, Cummings J, Cole G. Oral curcumin for Alzheimer's disease:tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study. Alzheimer's Research&Therapy. 2012;4(5):43. 

    상세보기 crossref

  15. Okahara K, Ishida Y, Hayashi Y, Inoue T, Tsuruta K, Takeuchi K, Yoshimuta H, Kiue K, Ninomiya Y, Kawano J, Yoshida K, Noda S, Tomita S, Fujimoto M, Hosomi J, Mitsuyama Y. Effects of Yokukansan on behavioral and psychological symptoms of dementia in regular treatment for Alzheimer's disease. Progress in Neuro-Psychopharmacology&Biological Psychiatry. 2010;34:532-6. 

    상세보기 crossref

  16. Monji A, Takita M, Samejima T, Takaishi T, Hashimoto K, Matsunaga H, Oda M, Sumida Y, Mizoguchi Y, Kato T, Horikawa H, Kanba S. Effect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer's disease. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2009;33:308-11. 

    상세보기 crossref

  17. Yancheva S, Ihl R, Nikolova G, Panayotov P, Schlaefke S, Hoerr R. Ginkgo biloba extract EGb 761, donepezil or both combined in the treatment of Alzheimer's disease with neuropsychiatric features: A randomised, doubleblind, exploratory trial. Aging&Mental Health. 2014;13(2): 183-90. 

    상세보기 crossref

  18. Cho KH, Kim TH, Jin C, Lee JE, Kwon SW. The Literary Trends of Herbal Prescription Ukgan-san and its Application in Modern Traditional Korean Medicine. Journal of Korean Medicine. 2018;39(3):17-27. 

    원문보기 상세보기 crossref

  19. Japanese Society of Neurology. Clinical Practice Guidelines Containing Kampo Product in Japan. Task Force for Clinical Practice Guidelines(CPG-TF) Committee for EBM. 2019. 

  20. Singh S, Srivastav S, Castellani R, Plascencia-Villa G, Perry G. Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders. Neurotherapeutics. 2019;16(3):666-74. 

    상세보기 crossref

  21. Savaskan E, Mueller H, Hoerr R, Gunten A, Gauthier S. Treatment effects of Ginkgo biloba extarct EGb 761 on the spectrum of behavioral and psychological symptoms of dementia: meta-analysis of randomized controlled trials. International Psychogeriatrics. 2018;30(3):285-93. 

    상세보기 crossref

  22. Han WJ, Kim HS, Kim ST, Kim TH, Lee YS, Kang HW. Comparative effects of Radix Polygalae and Rhizoma Acori Graminei on CT105-induced neuroblastoma cell lines. Journal of oriental neuropsychiatry. 2003;14(2):95-105. 

  23. Korean Neuropsychiatric Association. Textbook of neuropsychiatry. iMiS COMPANY. 2016;588-9. 

  24. Korean Neuropsychiatric Association. Textbook of neuropsychiatry. iMiS COMPANY. 2016;795. 

  25. Choi SH. Assessment Scale for Behavioral and Psychological Symptoms of Dementia. Dementia and Neurocognitive Disorders. 2004;3:9-13. 

  26. Lin S, Tsai Y, Lai J, Wu C. Demographic and medication characteristics of traditional Chinese medicine users among dementia patients in Taiwan:A nationwide database study. Journal of Ethnopharmacology. 2015;23:108-15. 

  27. Hyde A, May B, Dong L, Feng M, Liu S, Guo X, Zhang A, Lu C, Xue C. Behavioural and psychological symptoms of dementia(BPSD): A systematic review and meta-analysis. Journal of Psychopharmacology. 2017;31(2):169-83. 

    상세보기 crossref

  28. Yoon KJ, Lee AY, Kim HS, Choi JH, Lee JA, Kim NK, Hwang DK, Lee SY. Evaluation and study of the 2nd stage pilot project in collaboration with western medicine and oriental medicine. Korea Institute for Health and Social Affairs. 2018;30-36. 

  29. Kim JH, Kim SK, Han JM, Yea SJ, Kim C, Jang HC, Song MY. Analysis of Studies on Combined Medication of the Oriental and the Western Medicines. The Journal of Oriental Medical Preventive. 2009;13(3):1-18. 

저자의 다른 논문 :

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로